Trinity Biotech Plc
Research Trinity Biotech Plc (TRIB) on Bullrun: market cap USD 132.85M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerTRIB
- ExchangeNASDAQ
- CountryIreland
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 132.85M
- Financial periodFY2025
- RevenueUSD 43.79M
- Revenue growth-28.9%
- Net income-USD 37.38M
- Free cash flow-USD 12.15M
- Gross margin38.6%
Valuation Snapshot
latest market cap is USD 132.85M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 43.79M | -USD 37.38M | -USD 12.15M | 38.6% | n/a | USD 5.14M | USD 137.98M | -USD 71.98M |
| FY2024 | USD 61.56M | -USD 31.79M | -USD 14.26M | 34.8% | -53.1 | USD 5.17M | USD 100.76M | -USD 35.18M |
| FY2023 | USD 56.83M | -USD 24.02M | -USD 14.26M | 34.2% | -480 | USD 3.69M | USD 67.43M | -USD 23.95M |
| FY2022 | USD 62.52M | -USD 41.01M | -USD 6.90M | 27.6% | -182.4 | USD 6.58M | USD 72.20M | -USD 2.18M |
| FY2021 | USD 81.15M | USD 875.00K | USD 4.55M | 41.2% | 0.2 | USD 25.91M | USD 99.16M | -USD 319.00K |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 132.85M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 14.72M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 15.80M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 16.43M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 37.73M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 29.89M | 3.7 | n/a | n/a |
About Trinity Biotech Plc
Trinity Biotech plc, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Asia, Africa, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases, such as syphilis and herpes; SARS-CoV-2;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Trinity Biotech Plc's market cap?
Trinity Biotech Plc's market capitalization is USD 132.85M.
What does Trinity Biotech Plc do?
Trinity Biotech plc, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Asia, Africa, and Europe.